The trial will assess the pharmacodynamics, tolerability, safety, and pharmacokinetics of HM43239 in R/R AML patients.
The Phase I study will assess the pharmacokinetics, tolerability, and safety of EP262 in healthy volunteers.
The trial will evaluate SBI-100 OE in primary open angle glaucoma or ocular hypertension patients.
The trial will assess the tolerability, preliminary clinical activity, and safety of STAR0602 as a monotherapy.
Participants treated with XC001 showed improvements in ischaemic burden and total exercise duration.
Get industry leading news, data and analysis delivered to your inbox
The trial will assess the safety and pharmacokinetics of Orladeyo in paediatric HAE patients.
At week six, the ACI-24.060 vaccine elicited an anti-Abeta antibody response in ABATE’s first, low dose cohort of AD patients.
The trial assessed the safety and efficacy of IV SPL026 with supportive therapy in 34 MDD patients.
The trial will assess pitolisant’s efficacy and safety in Japanese OSAS patients who are complaining of EDS.
The NH study will enable the characterisation of OPMD patient disposition at baseline.